High-affinity Anticalins with aggregation-blocking activity directed against the Alzheimer beta-amyloid peptide.
Rauth, S., Hinz, D., Borger, M., Uhrig, M., Mayhaus, M., Riemenschneider, M., Skerra, A.(2016) Biochem J 473: 1563-1578
- PubMed: 27029347 
- DOI: 10.1042/BCJ20160114
- Primary Citation of Related Structures:  
4MVI, 4MVK, 4MVL - PubMed Abstract: 
Amyloid beta (Aβ) peptides, in particular Aβ42 and Aβ40, exert neurotoxic effects and their overproduction leads to amyloid deposits in the brain, thus constituting an important biomolecular target for treatments of Alzheimer's disease (AD). We describe the engineering of cognate Anticalins as a novel type of neutralizing protein reagent based on the human lipocalin scaffold ...